medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Number 3

<< Back

Rev Invest Clin 2017; 69 (3)

Geriatric Syndromes and Not Cardiovascular Risk Factors are Associated with Cognitive Impairment among Mexican Community-Dwelling Elderly with Type 2 Diabetes

Bello-Chavolla OY, Aguilar-Salinas CA, Avila-Funes JA

Language: English
References: 34
Page: 166-172
PDF size: 75.12 Kb.


ABSTRACT

Background: The association of cognitive impairment and type 2 diabetes has been consistently shown in several studies, yet its association with geriatric syndromes has not been fully explored. Objective: To study the correlates of cognitive impairment among community-dwelling elderly with type 2 diabetes. Methods: Cross-sectional study of 135 diabetic persons aged 70 years or older participating in the Coyoacán Cohort Study in Mexico City. Baseline data included chronic illnesses, geriatric syndromes, and diabetes-related variables. The lowest quartile in both the Mini-Mental State Examination and the Isaacs Set Test, according to age and schooling, was used to identify participants with cognitive impairment. Multivariate logistic regression analyses were used to identify the correlates of cognitive impairment. Results: Mean age of participants was 77.7 ± 5.8 years. The prevalence of cognitive impairment was 14.1%. Univariate logistic regression analyses showed that diabetic nephropathy, depression symptoms, falls, and frailty were associated with cognitive impairment. Multivariate logistic regression analyses showed that urinary incontinence and frailty were independently associated with cognitive impairment. Cardiovascular risk factors and diabetes-related variables did not show significant association to cognitive impairment. Conclusions: Geriatric syndromes, but not cardiovascular risk factors, were independently associated with cognitive impairment among diabetic elderlies. Intentional evaluation of these conditions may be important to improve management of the elderly patient with type 2 diabetes and cognitive impairment.


REFERENCES

  1. Aguilar-Salinas CA, Velazquez Monroy O, Gómez-Pérez FJ, et al. Characteristics of patients with type 2 diabetes in México: Results from a large population-based nationwide survey. Diabetes Care. 2003;26:2021-6.

  2. Rojas-Martínez R, Aguilar-Salinas CA, Jiménez-Corona A, Gómez- Pérez FJ, Barquera S, Lazcano-Ponce E. Prevalence of obesity and metabolic syndrome components in Mexican adults without type 2 diabetes or hypertension. Salud Publica Mex. 2012;54:7-12.

  3. Wilson RS, Barnes LL, Krueger KR, Hoganson G, Bienias JL, Bennett DA. Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc. 2005;11:400-7.

  4. Arvanitakis Z, Wilson RS, Bennett DA. Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging. 2006;10:287-91.

  5. Mayeda ER, Haan MN, Yaffe K, Kanaya AM, Neuhaus J. Does type 2 diabetes increase rate of cognitive decline in older Mexican Americans? Alzheimer Dis Assoc Disord. 2015;29:206-12.

  6. Bangen KJ, Gu Y, Gross AL, et al. Relationship between type 2 diabetes mellitus and cognitive change in a multiethnic elderly cohort. J Am Geriatr Soc. 2015;63:1075-83.

  7. Sadanand S, Balachandar R, Bharath S. Memory and executive functions in persons with type 2 diabetes: a meta-analysis. Diabetes Metab Res Rev. 2016;32:132-42.

  8. Rosso AL, Eaton CB, Wallace R, et al. Combined impact of geriatric syndromes and cardiometabolic diseases on measures of functional impairment. J Gerontol A Biol Sci Med Sci. 2011;66:349-54.

  9. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One. 2009;4:e4144.

  10. Mokri H, Avila-Funes JA, Meillon C, Gutiérrez Robledo LM, Amieva H. Normative data for the Mini-Mental State Examination, the Free and Cued Selective Reminding Test and the Isaacs Set Test for an older adult Mexican population: the Coyoacán Cohort Study. Clin Neuropsychol. 2013;27:1004-18.

  11. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-56.

  12. Avila-Funes JA, Medina-Campos RH, Tamez-Rivera O. Frailty is associated with disability and recent hospitalization in community- dwelling elderly: The Coyoacan Cohort. J Frailty Aging. 2014;3:206-10.

  13. Inouye S, Studenski S, Tinetti M, Kuchel GA. Geriatric syndromes: Clinical, research and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55:780-91.

  14. Sheikh JL, Yesavage JA. Geriatric Depression Scale (GDS). Recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165-72.

  15. Walckiers D, Van der Heyden J, Tafforeau J. Factors associated with excessive polypharmacy in older people. Arch Public Health. 2015;73:50.

  16. Beard HA, Markides KS, Al Ghatrif M, Kuo YF, Raji MA. Trends in diabetes medication use and prevalence of geriatric syndromes in older Mexican Americans from 1993/1994 to 2004/2005. Ann Pharmacother. 2010;44:1376-83.

  17. Luchsinger JA. Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention? J Alzheimers Dis. 2010;20:723-36.

  18. Abbatecola AM, Paolisso G, Sinclair AJ. Treating diabetes mellitus in older and oldest old patients. Curr Pharm Des. 2015;21:1665-71.

  19. Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clin Interv Aging. 2014;9:1011-19.

  20. de Bresser J, Reijmer YD, van den Berg E. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord. 2010;30:381-6.

  21. Avila-Funes JA, Carcaillon L, Helmer C, et al. Is frailty a prodromal stage of vascular dementia? Results from the Three-City Study. J Am Geriatr Soc. 2012;60:1708-12.

  22. Avila-Funes JA, Amieva H, Barberger-Gateau P, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc. 2009;57:453-61.

  23. García-Esquinas E, Graciani A, Guallar-Castillón P, López-García E, Rodríguez-Mañas L, Rodríguez-Artalejo F. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults. J Am Med Dir Assoc. 2015;16:748-54.

  24. Hubbard RE, Andrew MK, Fallah N, Rockwood K. Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diabet Med. 2010;27:603-6.

  25. Cobo A, Vázquez LA, Reviriego J, Rodríguez-Mañas L. Impact of frailty in older patients with diabetes mellitus: An overview. Endocrinol Nutr. 2016;63:291-303

  26. Cacciatore F, Testa G, Galizia G. Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta Diabetol. 2013;50:251-60.

  27. Umegaki H. Sarcopenia and frailty in older patients with diabetes mellitus. Geriatr Gerontol Int. 2016;16:293-9.

  28. Weinberg AE, Leppert JT, Elliott CS. Biochemical measures of diabetes are not independent predictors of urinary incontinence in women. J Urol. 2015;194:1668-74.

  29. Hsu A, Conell-Price J, Stijacic Cenzer I, et al. Predictors of urinary incontinence in community-dwelling frail older adults with diabetes mellitus in a cross-sectional study. BMC Geriatr. 2014;14:137.

  30. Hugenschmidt CE, Lovato JF, Ambrosius WT, Bryan RN, Gerstein HC, Horowitz KR, et al. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2014;37:3244-52.

  31. Ng TP, Feng L, Nyunt MS, Feng L, Gao Q, Lim ML. Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort. JAMA Neurol. 2016;73:456-63.

  32. Solfrizzi V, Scafato E, Capurso C, et al. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging. 2011;32:1932-41.

  33. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 2007;69:979-85.

  34. Geijselaers SL, Sep SJ, Schram MT, van Boxtel MP, van Sloten TT, Henry RM. Carotid stiffness is associated with impairment of cognitive performance in individuals with and without type 2 diabetes. The Maastricht Study. Atherosclerosis. 2016;253:186-93.




2020     |     www.medigraphic.com